Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Spitzberg K, Kersting A, Arolt V, Heindel W, Pfleiderer B.

Schizophr Res. 2005 Mar 1;73(2-3):153-7.

PMID:
15653258
2.

What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.

Abbott C, Bustillo J.

Curr Opin Psychiatry. 2006 Mar;19(2):135-9. Review.

PMID:
16612192
3.

Proton magnetic resonance spectroscopy of the human brain in schizophrenia.

Deicken RF, Johnson C, Pegues M.

Rev Neurosci. 2000;11(2-3):147-58. Review.

PMID:
10718151
4.

N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration.

Molina V, Sánchez J, Reig S, Sanz J, Benito C, Santamarta C, Pascau J, Sarramea F, Gispert JD, Misiego JM, Palomo T, Desco M.

Schizophr Res. 2005 Mar 1;73(2-3):209-19. Review.

PMID:
15653263
5.

Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia.

Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn JD, Frank JA, Berman KF, Weinberger DR.

Am J Psychiatry. 2000 Jan;157(1):26-33. Review.

PMID:
10618009
6.

Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex.

Ohnuma T, Suzuki T, Arai H.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):889-94. Review.

PMID:
15949884
7.

Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.

Poels EM, Kegeles LS, Kantrowitz JT, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR.

Schizophr Res. 2014 Feb;152(2-3):325-32. doi: 10.1016/j.schres.2013.12.013. Epub 2014 Jan 11. Review.

Items per page

Supplemental Content

Write to the Help Desk